Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Trends in Pharmacological Sciences|April 23, 2015
Menstruation pulls the trigger for inflammation and pain in endometriosisAlexis Laux-Biehlmann, Thomas d'Hooghe, Thomas M ZollnerJournal of Neuroscience Methods|May 28, 2014
Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the ratMichael Gruen, Alexis Laux-Biehlmann, Thomas M Zollner, et al.Frontiers in Behavioral Neuroscience|February 27, 2023
Anxiety-related behaviors without observation of generalized pain in a mouse model of endometriosisPaulina Nunez-Badinez, Alexis Laux-Biehlmann, Michael D Hayward, et al.Frontiers in Cellular Neuroscience|July 24, 2019
Corrigendum: Morphine Binds Creatine Kinase B and Inhibits Its ActivityIvan Weinsanto, Jinane Mouheiche, Alexis Laux-Biehlmann, et al.Frontiers in Cellular Neuroscience|December 19, 2018
Morphine Binds Creatine Kinase B and Inhibits Its ActivityIvan Weinsanto, Jinane Mouheiche, Alexis Laux-Biehlmann, et al.Molecular Pain|January 23, 2018
Lithium reverses mechanical allodynia through a mu opioid-dependent mechanismIvan Weinsanto, Jinane Mouheiche, Alexis Laux-Biehlmann, et al.Molecular Pharmacology|June 22, 2023
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorGernot Langer, John Scott, Christoffer Lind, et al.Biofactors (Oxford, England)|July 18, 2013
Endogenous morphine-6-glucuronide (M6G) is present in the plasma of patients: validation of a specific anti-M6G antibody for clinical and basic researchAlexis Laux-Biehlmann, Hélène Chung, Jinane Mouheiche, et al.British Journal of Pharmacology|July 28, 2018
Stable isotope-labelled morphine to study in vivo central and peripheral morphine glucuronidation and brain transport in tolerant miceIvan Weinsanto, Alexis Laux-Biehlmann, Jinane Mouheiche, et al.Journal of Medicinal Chemistry|November 21, 2019
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction ProfileStefan Werner, Stefanie Mesch, Roman C Hillig, et al.Pageof 2